A major American pharmaceutical corporation has announced it could have a coronavirus vaccine ready by the fall, according to a report by DailyMail..
Pfizer Chief Executive Officer Albert Bourla said on Tuesday a coronavirus vaccine for emergency use could be ready by the autumn and for broader roll out by the end of 2020.
It has already started testing the vaccine on humans in Germany with its partner firm BioNTech and hopes to begin testing in America soon.
The company has already started mass manufacturing doses while trials are underway and is aiming to have ‘hundred of millions of doses ready for the end of the year.
Developing vaccinations usually takes many months or years but researchers are hurtling towards human trials. They say the process has been made easier because the virus is not mutating and is similar to other viruses seen in the past.
University of Oxford scientists are also confident they can get their jab for the incurable virus rolled out for millions to use by autumn.
As many as 100 potential COVID-19 candidate vaccines are now under development by biotech and research teams around the world, and at least five of these are in preliminary testing in people in what are known as Phase 1 clinical trials.
